Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Clin Chem ; 68(12): 1502-1508, 2022 12 06.
Article in English | MEDLINE | ID: mdl-36308332

ABSTRACT

BACKGROUND: The ceramide- and phospholipid-based cardiovascular risk score (CERT2) has been found to predict the risk for cardiovascular disease (CVD) events, especially cardiovascular mortality. In the present study, our aim was to estimate the predictive ability of CERT2 for mortality of CVD, coronary artery disease (CAD), and stroke in the elderly and to compare these results with those of conventional lipids. METHODS: We conducted a prospective study with an 18-year follow-up period that included a total of 1260 participants ages ≥64 years. Ceramides and phosphatidylcholines were analyzed using a LC-MS. Total cholesterol and triglycerides were performed by enzymatic methods and HDL cholesterol was determined by a direct enzymatic method. Concentrations of LDL-cholesterol were calculated according to the Friedewald formula. RESULTS: A higher score of CERT2 was significantly associated with higher CVD, CAD, and stroke mortality during the 18-year follow-up both in unadjusted and adjusted Cox regression models. The unadjusted hazard ratios (HRs) of CERT2 (95% CI) per SD for CVD, CAD, and stroke were 1.72 (1.52-1.96), 1.76 (1.52-2.04), and 1.63 (1.27-2.10), respectively, and the corresponding adjusted HRs (95% CI) per SD for CERT2 were 1.48 (1.29-1.69), 1.50 (1.28-1.75), and 1.41 (1.09-1.83). For conventional lipids, HRs per SD were lower than for CERT2. CONCLUSIONS: The risk score CERT2 associated strongly with CVD, CAD, and stroke mortality in the elderly, while the association between these events and conventional lipids was weak.


Subject(s)
Cardiovascular Diseases , Coronary Artery Disease , Stroke , Humans , Aged , Middle Aged , Ceramides , Prospective Studies , Phosphatidylcholines , Cholesterol, LDL , Cholesterol, HDL , Risk Factors
2.
Age Ageing ; 42(1): 110-3, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22693160

ABSTRACT

BACKGROUND AND OBJECTIVE: the data concerning the predictive role of oxidised LDL (ox-LDL) in all-cause mortality are scarce. We investigated whether circulating ox-LDL would stand out as a risk factor of total mortality in the elderly. Study subjects, design and methods: a total of 1,260 elderly inhabitants (533 men, 727 women) aged 64 years or more from Lieto, South-Western Finland participated the study in 1998-99. Medical records were re-examined approximately a decade later in January 2009. Circulating ox-LDL lipids were used as the main outcome measure. The comparisons were obtained by the Cox hazard ratio model. RESULTS: during the 10-year follow-up, 467 participants had died (37%), of whom 36% had died of atherosclerotic cardiovascular diseases. Ox-LDL was a significant predictor of all-cause mortality, when proportioned to low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c) or apolipoprotein A1 (apoA1). These findings were independent of age, sex, body mass index, smoking, blood pressure and diabetes (P < 0.05 for all). CONCLUSION: circulating ox-LDL lipids, when proportioned to LDL-c, HDL-c or apoaA1, stand out as a risk factor for all-cause mortality independent of major confounding attributes. In the prospective survival and increasing disease burden caused by accumulating age, oxidative stress may have a considerable role.


Subject(s)
Apolipoprotein A-I/blood , Cholesterol, HDL/blood , Lipoproteins, LDL/blood , Mortality , Aged , Aged, 80 and over , Cholesterol, LDL/blood , Female , Finland/epidemiology , Humans , Longitudinal Studies , Male , Middle Aged , Predictive Value of Tests , Proportional Hazards Models , Risk Factors
3.
Endocr Pract ; 13(5): 451-7, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17872345

ABSTRACT

OBJECTIVE: To analyze associations between thyroid-stimulating hormone (TSH) and free thyroxine (FT4 concentrations and life satisfaction, symptoms, self-rated health, and common neuropsychiatric diseases (depression or dementia) in a community-dwelling elderly population to provide evidence whether to decrease the upper reference limit for TSH or the optimal TSH target in levothyroxine treatment in older adults. METHODS: In this cross-sectional study, we determined TSH and FT4 concentrations in a thyroid disease-free population of 502 men (median age, 71 years) and 584 women (median age, 73 years) and in a patient group of 49 women (median age, 75 years) with primary hypothyroidism who were stable users of thyroxine treatment. Life satisfaction, self-rated health, depression, and dementia were assessed with specific questions and with tools such as the Self-report Depression Scale and the Mini-Mental State Examination. Independent variables were dichotomized, and associations of these variables with TSH and FT4 levels were assessed in the thyroid disease-free population. Levels of TSH and FT4 in thyroid disease-free women and in women treated with thyroxine were also compared. RESULTS: After age adjustment, there were no associations between TSH levels and self-rated health, life satisfaction, or most symptoms in the thyroid disease-free population. No associations were found between diagnosed depression or Mini-Mental State Examination results and levels of TSH and FT4. Dementia was associated with higher FT4 concentration in men. Although women treated with thyroxine had TSH levels that were higher than thyroid disease-free women, there were no statistically significant differences in independent variables between these 2 groups. CONCLUSION: Our results do not support the need to decrease the upper reference limit for TSH or to lower the optimal TSH target in levothyroxine treatment in older adults, as recommended in recent guidelines.


Subject(s)
Health Status , Hypothyroidism/epidemiology , Quality of Life , Thyrotropin/blood , Thyroxine/blood , Age Distribution , Aged , Aged, 80 and over , Chemistry, Clinical/standards , Cross-Sectional Studies , Dementia/diagnosis , Dementia/epidemiology , Depression/diagnosis , Depression/epidemiology , Female , Geriatrics/standards , Humans , Hypothyroidism/blood , Hypothyroidism/drug therapy , Hypothyroidism/psychology , Male , Practice Guidelines as Topic , Reference Values , Thyroxine/therapeutic use
4.
Dement Geriatr Cogn Disord ; 18(3-4): 321-9, 2004.
Article in English | MEDLINE | ID: mdl-15305110

ABSTRACT

OBJECTIVE: To study undiagnosed diseases in older people with and without dementia. DESIGN: Cross-sectional population-based study in Lieto, southwestern Finland. PARTICIPANTS: All the inhabitants aged 64 and more in Lieto. Participation rate was 82% (n = 1,260). MEASUREMENTS: Dementia and its subtypes were diagnosed according to prevailing criteria. Medical conditions were assessed in clinical examinations and from medical records. RESULTS: 112 patients with dementia were found; 66% of them had at least 1 undiagnosed disease compared to 48% of the non-demented group (p = 0.041). The demented subjects had more undiagnosed hypercholesterolaemia (p = 0.039) and undiagnosed hypothyroidism (p = 0.032) than the controls. CONCLUSION: Undiagnosing is more common among patients with dementia. Screening strategies should be developed further to find these patients.


Subject(s)
Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/epidemiology , Dementia/epidemiology , Hypothyroidism/diagnosis , Hypothyroidism/epidemiology , Catchment Area, Health , Central Nervous System Diseases/diagnosis , Central Nervous System Diseases/epidemiology , Comorbidity , Cross-Sectional Studies , Dementia/diagnosis , Diagnostic and Statistical Manual of Mental Disorders , Electrocardiography , Female , Finland/epidemiology , Humans , Male , Middle Aged , Population Surveillance/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...